Skip to content
BiopasGroup
  • Our Company
    • About us
    • Our Values
    • Why Biopas
  • Disease areas
  • Responsability
    • Pharmacovigilance
    • Compliance
    • Quality policy
  • Newsroom
  • Partnering
  • Contact us
×
  • Our Company
    • About us
    • Our Values
    • Why Biopas
  • Disease areas
  • Responsability
    • Pharmacovigilance
    • Compliance
    • Quality policy
  • Newsroom
  • Partnering
  • Contact us

Acorda Therapeutics and Biopas Laboratories Announce Agreement to Commercialize INBRIJA® in Latin America

Under the terms of the agreements, Acorda will receive a significant, double-digit, tiered percentage of the selling price of INBRIJA in Latin America in exchange for supply of the product. Acorda will also receive sales-based milestones. Biopas will have the exclusive distribution rights to INBRIJA in nine countries within Latin America, including Brazil and Mexico

Continue reading

Biopas  is a leading and differentiated Latin American pharmaceutical company, focused on in-licensing, marketing, and selling of cutting-edge specialty pharmaceutical products.

The company holds leading positions in CNS, Immunology, Dermatology, Oncology and Orphan Drugs and operates in all of LatAm with fully owned subsidiaries and more than 250 employees in Latin America.

Biopas is focused on innovative and differentiated products, offering multiple therapeutic options to specialists in niche indications that cover unmet medical needs of patients.

Sitemap

  • Our Company
    • About us
    • Our Values
    • Why Biopas
  • Disease areas
  • Responsability
    • Pharmacovigilance
    • Compliance
    • Quality policy
  • Newsroom
  • Partnering
  • Contact us
×
  • Our Company
    • About us
    • Our Values
    • Why Biopas
  • Disease areas
  • Responsability
    • Pharmacovigilance
    • Compliance
    • Quality policy
  • Newsroom
  • Partnering
  • Contact us

Contact us

Linkedin Instagram Youtube

Links

  • BiopasMed
  • Pagos Biopas Belle

AV-VAR-VAR-S01-2021-Vig.SEP2023-VAR© Biopas Group 2022 // Laboratorios Biopas S.A.  All rights reserved